Collegium shareholders elect all eight director nominees, approve say-on-pay, ratify Deloitte

COLLEGIUM PHARMACEUTICAL, INC

All eight director nominees elected with 25.9M to 27.4M votes for each; broker non-votes 1.79M.
Advisory vote on executive compensation approved: 26.3M for, 1.1M against, 5.6K abstentions.
Ratification of Deloitte & Touche as auditor for FY 2026 passed: 28.95M for, 252.8K against.
Meeting held May 14, 2026; 29.2M of 32.4M shares present in person or by proxy.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.